Santen to Purchase Own Shares
(Buyback of shares pursuant to the provision of its Articles of Incorporation in accordance with Article 165, paragraph 2 of the Companies Act)
|
|
Osaka, Japan, January 30, 2008---Santen Pharmaceutical Co., Ltd. announced that a resolution has been adopted at the Board of Directors meeting held on January 30, 2008. Santen will aquire its own shares pursuant to Article 156 which is applicable in accordance to Article 165, paragraph 3 of the Companies Act of Japan.
1. Reasons for the purchase of its own shares
In order to improve capital efficiency and enhance return to shareholders |
|
| 2. Contents of purchase |
| (1) Class of shares to be purchased: |
Common stock of the company |
| (2) Total numbers of shares to be purchased: |
1,850,000 shares (maximum)
(The percentage compared to the total number of shares issued not including treasury stock: 2.1%) |
| (3) Gross amount of shares to be purchased: |
5,000,000,000 yen (maximum) |
| (4) Period of purchase: |
From Feburary 1, 2008 to March 24, 2008 |
|
Reference:
The number of own shares, as of December 31, 2007 |
|
| Gross number of shares issued (Not including treasury stock): |
86,802,620 shares |
| The number of treasury shares: |
54,783shares |
|
|
|
|
|
Back to top
|
|
|
|
